Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells.

Nozawa K, Kawabata-Shoda E, Doihara H, Kojima R, Okada H, Mochizuki S, Sano Y, Inamura K, Matsushime H, Koizumi T, Yokoyama T, Ito H.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3408-13. doi: 10.1073/pnas.0805323106. Epub 2009 Feb 11.

2.

The evolutionarily conserved G protein-coupled receptor SREB2/GPR85 influences brain size, behavior, and vulnerability to schizophrenia.

Matsumoto M, Straub RE, Marenco S, Nicodemus KK, Matsumoto S, Fujikawa A, Miyoshi S, Shobo M, Takahashi S, Yarimizu J, Yuri M, Hiramoto M, Morita S, Yokota H, Sasayama T, Terai K, Yoshino M, Miyake A, Callicott JH, Egan MF, Meyer-Lindenberg A, Kempf L, Honea R, Vakkalanka RK, Takasaki J, Kamohara M, Soga T, Hiyama H, Ishii H, Matsuo A, Nishimura S, Matsuoka N, Kobori M, Matsushime H, Katoh M, Furuichi K, Weinberger DR.

Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6133-8. doi: 10.1073/pnas.0710717105. Epub 2008 Apr 14.

3.

YM753, a novel histone deacetylase inhibitor, exhibits antitumor activity with selective, sustained accumulation of acetylated histones in tumors in the WiDr xenograft model.

Shindoh N, Mori M, Terada Y, Oda K, Amino N, Kita A, Taniguchi M, Sohda KY, Nagai K, Sowa Y, Masuoka Y, Orita M, Sasamata M, Matsushime H, Furuichi K, Sakai T.

Int J Oncol. 2008 Mar;32(3):545-55.

PMID:
18292931
4.

Diabetic modifier QTLs in F(2) intercrosses carrying homozygous transgene of TGF-beta.

Suzuki T, Moritani M, Yoshino M, Kagami M, Iwasaki S, Nishimura K, Akamatsu M, Kobori M, Matsushime H, Kotoh M, Furuichi K, Itakura M.

Mamm Genome. 2008 Jan;19(1):15-25. Epub 2007 Dec 27.

PMID:
18160996
5.

Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2.

Matsumoto S, Yamazaki C, Masumoto KH, Nagano M, Naito M, Soga T, Hiyama H, Matsumoto M, Takasaki J, Kamohara M, Matsuo A, Ishii H, Kobori M, Katoh M, Matsushime H, Furuichi K, Shigeyoshi Y.

Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4140-5. Epub 2006 Mar 2.

6.

Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor.

Soga T, Ohishi T, Matsui T, Saito T, Matsumoto M, Takasaki J, Matsumoto S, Kamohara M, Hiyama H, Yoshida S, Momose K, Ueda Y, Matsushime H, Kobori M, Furuichi K.

Biochem Biophys Res Commun. 2005 Jan 28;326(4):744-51. Erratum in: Biochem Biophys Res Commun. 2005 Apr 1;329(1):417.

PMID:
15607732
7.

A novel two-pore domain K+ channel, TRESK, is localized in the spinal cord.

Sano Y, Inamura K, Miyake A, Mochizuki S, Kitada C, Yokoi H, Nozawa K, Okada H, Matsushime H, Furuichi K.

J Biol Chem. 2003 Jul 25;278(30):27406-12. Epub 2003 May 17.

8.

Molecular identification of nicotinic acid receptor.

Soga T, Kamohara M, Takasaki J, Matsumoto S, Saito T, Ohishi T, Hiyama H, Matsuo A, Matsushime H, Furuichi K.

Biochem Biophys Res Commun. 2003 Mar 28;303(1):364-9.

PMID:
12646212
9.

Response to ADP-ribose by activation of TRPM2 in the CRI-G1 insulinoma cell line.

Inamura K, Sano Y, Mochizuki S, Yokoi H, Miyake A, Nozawa K, Kitada C, Matsushime H, Furuichi K.

J Membr Biol. 2003 Feb 1;191(3):201-7.

PMID:
12571754
10.

Molecular cloning and characterization of prokineticin receptors.

Soga T, Matsumoto Si, Oda T, Saito T, Hiyama H, Takasaki J, Kamohara M, Ohishi T, Matsushime H, Furuichi K.

Biochim Biophys Acta. 2002 Dec 12;1579(2-3):173-9.

PMID:
12427552
11.

cDNA cloning and characterization of porcine histamine H4 receptor.

Oda T, Matsumoto S, Masuho Y, Takasaki J, Matsumoto M, Kamohara M, Saito T, Ohishi T, Soga T, Hiyama H, Matsushime H, Furuichi K.

Biochim Biophys Acta. 2002 May 3;1575(1-3):135-8.

PMID:
12020829
12.

Molecular cloning and characterization of Kv6.3, a novel modulatory subunit for voltage-gated K(+) channel Kv2.1.

Sano Y, Mochizuki S, Miyake A, Kitada C, Inamura K, Yokoi H, Nozawa K, Matsushime H, Furuichi K.

FEBS Lett. 2002 Feb 13;512(1-3):230-4.

13.

Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells.

Kamohara M, Takasaki J, Matsumoto M, Matsumoto Si, Saito T, Soga T, Matsushime H, Furuichi K.

Biochem Biophys Res Commun. 2001 Oct 12;287(5):1088-92.

PMID:
11587533
14.

Immunocyte Ca2+ influx system mediated by LTRPC2.

Sano Y, Inamura K, Miyake A, Mochizuki S, Yokoi H, Matsushime H, Furuichi K.

Science. 2001 Aug 17;293(5533):1327-30.

15.

Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor.

Takasaki J, Kamohara M, Saito T, Matsumoto M, Matsumoto S, Ohishi T, Soga T, Matsushime H, Furuichi K.

Mol Pharmacol. 2001 Sep;60(3):432-9.

PMID:
11502873
16.

Rapid downregulation of cyclin D1 mRNA and protein levels by ultraviolet irradiation in murine macrophage cells.

Miyakawa Y, Matsushime H.

Biochem Biophys Res Commun. 2001 Jun 1;284(1):71-6.

PMID:
11374872
17.

Cdk4 activation is dependent on the subunit rearrangement in the complexes.

Takahashi H, Menjo M, Kaneko Y, Ikeda K, Matsushime H, Nakanishi M.

Biochem Biophys Res Commun. 2000 Jan 7;267(1):388-93.

PMID:
10623629
18.

Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.

Nakanishi M, Kaneko Y, Matsushime H, Ikeda K.

Biochem Biophys Res Commun. 1999 Sep 16;263(1):35-40.

PMID:
10486249
20.

[G1-cyclin/Cdk and cancer].

Takahashi H, Matsushime H.

Tanpakushitsu Kakusan Koso. 1997 Jul;42(10 Suppl):1554-61. Review. Japanese. No abstract available.

PMID:
9279081
21.

Contact inhibition-induced inactivation of the cyclin D-dependent kinase in rat fibroblast cell line, 3Y1.

Kato A, Takahashi H, Takahashi Y, Matsushime H.

Leukemia. 1997 Apr;11 Suppl 3:361-2.

PMID:
9209390
22.

Two different bindings of p21 Cdk inhibitor to cyclin/Cdk complex.

Nakanishi M, Kagawa Y, Takahashi H, Matsushime H.

Leukemia. 1997 Apr;11 Suppl 3:356-7.

PMID:
9209388
23.

Inactivation of the cyclin D-dependent kinase in the rat fibroblast cell line, 3Y1, induced by contact inhibition.

Kato A, Takahashi H, Takahashi Y, Matsushime H.

J Biol Chem. 1997 Mar 21;272(12):8065-70.

24.
25.

Induction of G1 arrest by down-regulation of cyclin D3 in T cell hybridomas.

Miyatake S, Nakano H, Park SY, Yamazaki T, Takase K, Matsushime H, Kato A, Saito T.

J Exp Med. 1995 Aug 1;182(2):401-8.

26.

[Macrophage cell cycle control by M-CSF/CSF-1].

Matsushime H.

Rinsho Ketsueki. 1995 May;36(5):406-9. Review. Japanese.

PMID:
7783343
27.

[Cell cycle and parathyroid tumor].

Matsushime H.

Nihon Rinsho. 1995 Apr;53(4):844-9. Review. Japanese.

PMID:
7752470
28.

D-type cyclin-dependent kinase activity in mammalian cells.

Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY.

Mol Cell Biol. 1994 Mar;14(3):2066-76.

29.

Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.

Shibuya M, Seetharam L, Ishii Y, Sawano A, Gotoh N, Matsushime H, Yamaguchi S.

Princess Takamatsu Symp. 1994;24:162-70. Review.

PMID:
8983073
30.

Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.

Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT.

Cancer Res. 1993 Nov 15;53(22):5535-41.

32.

Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.

Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM.

Cell. 1993 May 7;73(3):487-97.

PMID:
8343202
33.
34.
35.

Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.

Matsushime H, Ewen ME, Strom DK, Kato JY, Hanks SK, Roussel MF, Sherr CJ.

Cell. 1992 Oct 16;71(2):323-34.

PMID:
1423597
36.

Genomic organization, chromosomal localization, and independent expression of human cyclin D genes.

Inaba T, Matsushime H, Valentine M, Roussel MF, Sherr CJ, Look AT.

Genomics. 1992 Jul;13(3):565-74.

PMID:
1386335
37.

Regulation of CYL/cyclin D genes by colony-stimulating factor 1.

Sherr CJ, Matsushime H, Roussel MF.

Ciba Found Symp. 1992;170:209-19; discussion 219-26. Review.

PMID:
1483347
38.

Cloning and expression of murine interleukin-1 receptor antagonist in macrophages stimulated by colony-stimulating factor 1.

Matsushime H, Roussel MF, Matsushima K, Hishinuma A, Sherr CJ.

Blood. 1991 Aug 1;78(3):616-23.

PMID:
1830498
39.

Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle.

Matsushime H, Roussel MF, Ashmun RA, Sherr CJ.

Cell. 1991 May 17;65(4):701-13.

PMID:
1827757
40.

Novel mammalian cyclins (CYL genes) expressed during G1.

Matsushime H, Roussel MF, Sherr CJ.

Cold Spring Harb Symp Quant Biol. 1991;56:69-74. Review. No abstract available.

PMID:
1726425
41.

A novel mammalian protein kinase gene (mak) is highly expressed in testicular germ cells at and after meiosis.

Matsushime H, Jinno A, Takagi N, Shibuya M.

Mol Cell Biol. 1990 May;10(5):2261-8.

43.

Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.

Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M.

Oncogene. 1990 Apr;5(4):519-24.

PMID:
2158038
44.

Isolation and characterization of new mammalian kinase genes by cross hybridization with a tyrosine kinase probe.

Shibuya M, Matsushime H, Yamane A, Ikeda T, Yoshida MC, Tojo A.

Princess Takamatsu Symp. 1989;20:103-10.

PMID:
2562176
45.

Undetectable bcr-abl rearrangements in some CML patients are due to a deletion mutation in the bcr gene.

Hirosawa S, Aoki N, Matsushime H, Shibuya M.

Am J Hematol. 1988 May;28(1):33-6.

PMID:
2835901
46.

Regional localization of the human c-ros-1 on 6q22 and flt on 13q12.

Satoh H, Yoshida MC, Matsushime H, Shibuya M, Sasaki M.

Jpn J Cancer Res. 1987 Aug;78(8):772-5.

PMID:
3115921
47.
48.
49.

Analysis of structure and activation of some receptor-type tyrosine kinase oncogenes.

Shibuya M, Matsushime H, Yamazaki H, Wang LH, Fukui Y, Ueyama Y, Tamaoki N.

Princess Takamatsu Symp. 1986;17:195-202.

PMID:
3455414

Supplemental Content

Loading ...
Support Center